Cargando…

Molecular Architect: A User-Friendly Workflow for Virtual Screening

[Image: see text] Computer-assisted drug design (CADD) methods have greatly contributed to the development of new drugs. Among CADD methodologies, virtual screening (VS) can enrich the compound collection with molecules that have the desired physicochemical and pharmacophoric characteristics that ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Maia, Eduardo H. B., Medaglia, Lucas Rolim, da Silva, Alisson Marques, Taranto, Alex G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114615/
https://www.ncbi.nlm.nih.gov/pubmed/32258898
http://dx.doi.org/10.1021/acsomega.9b04403
_version_ 1783513925493456896
author Maia, Eduardo H. B.
Medaglia, Lucas Rolim
da Silva, Alisson Marques
Taranto, Alex G.
author_facet Maia, Eduardo H. B.
Medaglia, Lucas Rolim
da Silva, Alisson Marques
Taranto, Alex G.
author_sort Maia, Eduardo H. B.
collection PubMed
description [Image: see text] Computer-assisted drug design (CADD) methods have greatly contributed to the development of new drugs. Among CADD methodologies, virtual screening (VS) can enrich the compound collection with molecules that have the desired physicochemical and pharmacophoric characteristics that are needed to become drugs. Many free tools are available for this purpose, but they are difficult to use and do not have a graphical user interface. Furthermore, several free tools must be used to carry out the entire VS process, requiring the user to process the results of one software program so that they can be used in another program, adding a potential source of human error. Moreover, some software programs require knowledge of advanced computational skills, such as programming languages. This context has motivated us to develop Molecular Architect (MolAr). MolAr is a workflow with a simple and intuitive interface that acts in an integrated and automated form to perform the entire VS process, from protein preparation (homology modeling and protonation state) to virtual screening. MolAr carries out VS through AutoDock Vina, DOCK 6, or a consensus of the two. Two case studies were conducted to demonstrate the performance of MolAr. In the first study, the feasibility of using MolAr for DNA–ligand systems was assessed. Both AutoDock Vina and DOCK 6 showed good results in performing VS in DNA–ligand systems. However, the use of consensus virtual screening was able to enrich the results. According to the area under the ROC curve and the enrichment factors, consensus VS was better able to predict the positions of the active ligands. The second case study was performed on 8 targets from the DUD-E database and 10 active ligands for each target. The results demonstrated that using the final ligand conformation provided by AutoDock Vina as an input for DOCK 6 improved the DOCK 6 ROC curves by up to 42% in VS. These case studies demonstrated that MolAr is capable conducting the VS process and is an easy-to-use and effective tool. MolAr is available for download free of charge at http: //www.drugdiscovery.com.br/software/.
format Online
Article
Text
id pubmed-7114615
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-71146152020-04-03 Molecular Architect: A User-Friendly Workflow for Virtual Screening Maia, Eduardo H. B. Medaglia, Lucas Rolim da Silva, Alisson Marques Taranto, Alex G. ACS Omega [Image: see text] Computer-assisted drug design (CADD) methods have greatly contributed to the development of new drugs. Among CADD methodologies, virtual screening (VS) can enrich the compound collection with molecules that have the desired physicochemical and pharmacophoric characteristics that are needed to become drugs. Many free tools are available for this purpose, but they are difficult to use and do not have a graphical user interface. Furthermore, several free tools must be used to carry out the entire VS process, requiring the user to process the results of one software program so that they can be used in another program, adding a potential source of human error. Moreover, some software programs require knowledge of advanced computational skills, such as programming languages. This context has motivated us to develop Molecular Architect (MolAr). MolAr is a workflow with a simple and intuitive interface that acts in an integrated and automated form to perform the entire VS process, from protein preparation (homology modeling and protonation state) to virtual screening. MolAr carries out VS through AutoDock Vina, DOCK 6, or a consensus of the two. Two case studies were conducted to demonstrate the performance of MolAr. In the first study, the feasibility of using MolAr for DNA–ligand systems was assessed. Both AutoDock Vina and DOCK 6 showed good results in performing VS in DNA–ligand systems. However, the use of consensus virtual screening was able to enrich the results. According to the area under the ROC curve and the enrichment factors, consensus VS was better able to predict the positions of the active ligands. The second case study was performed on 8 targets from the DUD-E database and 10 active ligands for each target. The results demonstrated that using the final ligand conformation provided by AutoDock Vina as an input for DOCK 6 improved the DOCK 6 ROC curves by up to 42% in VS. These case studies demonstrated that MolAr is capable conducting the VS process and is an easy-to-use and effective tool. MolAr is available for download free of charge at http: //www.drugdiscovery.com.br/software/. American Chemical Society 2020-03-20 /pmc/articles/PMC7114615/ /pubmed/32258898 http://dx.doi.org/10.1021/acsomega.9b04403 Text en Copyright © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Maia, Eduardo H. B.
Medaglia, Lucas Rolim
da Silva, Alisson Marques
Taranto, Alex G.
Molecular Architect: A User-Friendly Workflow for Virtual Screening
title Molecular Architect: A User-Friendly Workflow for Virtual Screening
title_full Molecular Architect: A User-Friendly Workflow for Virtual Screening
title_fullStr Molecular Architect: A User-Friendly Workflow for Virtual Screening
title_full_unstemmed Molecular Architect: A User-Friendly Workflow for Virtual Screening
title_short Molecular Architect: A User-Friendly Workflow for Virtual Screening
title_sort molecular architect: a user-friendly workflow for virtual screening
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114615/
https://www.ncbi.nlm.nih.gov/pubmed/32258898
http://dx.doi.org/10.1021/acsomega.9b04403
work_keys_str_mv AT maiaeduardohb moleculararchitectauserfriendlyworkflowforvirtualscreening
AT medaglialucasrolim moleculararchitectauserfriendlyworkflowforvirtualscreening
AT dasilvaalissonmarques moleculararchitectauserfriendlyworkflowforvirtualscreening
AT tarantoalexg moleculararchitectauserfriendlyworkflowforvirtualscreening